Lakefront Biotherapeutics (LKFT) Other Non-Current Assets (2013 - 2026)

Lakefront Biotherapeutics (LKFT) has reported Other Non-Current Assets for 13 consecutive years, with $3.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 21.5% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $3.5 million (up 21.5% YoY), while the FY2025 annual figure was $3.4 million, down 98.39% from the prior year.
• Other Non-Current Assets steadied at $3.5 million in Q1 2026 per LKFT's latest filing, from $3.4 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $5.2 billion in Q1 2022 and bottomed at $2.8 million in Q1 2025.
• Historically, Other Non-Current Assets has averaged $2.3 billion across 5 years, with a median of $3.7 billion in 2024.
• Annual changes were most pronounced in 2024 — Other Non-Current Assets jumped 1137.18% — and 2025, when it tumbled 99.93%.
• Lakefront Biotherapeutics' Other Non-Current Assets stood at $5.9 million in 2022, then surged by 193.31% to $17.3 million in 2023, then surged by 1137.18% to $213.9 million in 2024, then sank by 98.39% to $3.4 million in 2025, then gained by 0.41% to $3.5 million in 2026.
• Business Quant data shows LKFT's Other Non-Current Assets at $3.5 million in Q1 2026, $3.4 million in Q4 2025, and $2.9 million in Q3 2025.